fomesafen has been researched along with Chronic Hepatitis C in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ampuero, J; Fernández RodrÃguez, CM; Herrero, JI | 1 |
| Dicpinigaitis, PV; Weiner, FR | 1 |
2 other study(ies) available for fomesafen and Chronic Hepatitis C
| Article | Year |
|---|---|
Reflex testing. A key tool for the elimination of hepatitis C.
Topics: Antiviral Agents; Hepatitis C; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Reflex | 2020 |
Chronic cough associated with interferon/ribavirin therapy for hepatitis C.
Topics: Antiviral Agents; Capsaicin; Cough; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Reflex; Ribavirin; Sensory System Agents | 2011 |